MSB 1.78% $1.11 mesoblast limited

Alzheimer drug approved

  1. 154 Posts.
    lightbulb Created with Sketch. 74
    De FDA approved Aducanumab iwhich is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some prominent experts say there’s not enough evidence it can address cognitive symptoms.
    https://www.nytimes.com/2021/06/07/health/fda-approves-alzheimers-drug.html?smid=em-share
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
-0.020(1.78%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.12 $1.13 $1.09 $4.556M 4.141M

Buyers (Bids)

No. Vol. Price($)
2 9590 $1.10
 

Sellers (Offers)

Price($) Vol. No.
$1.11 3132 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.